Stocksigma LogoStocksigma Logo

Orchid Pharma Schedules Board Meeting for Q2 and H1 Results

Orchid Pharma Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited standalone and consolidated financial

Orchid Pharma Schedules Board Meeting for Q2 and H1 Results

Orchid Pharma Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Orchid Pharma Schedules Board Meeting for Q2 and H1 Results Orchid Pharma Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Orchid Pharma Ltd

All Orchid Pharma Ltd announcements